Gene · 5587
Papers3,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein kinase D: Integrating cancer and metabolic disorders. | Mol Aspects Med | 2026 | 41587506 | PubTator, text mining | PubMed |
| RoboA reinforces planarian stem cell fate through FoxA and Anosmin1a. | Nat Commun | 2026 | 41577713 | PubTator, text mining | PubMed |
| Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41484057 | PubTator, text mining | PubMed |
| Pharmacogenetics of incretin-based therapies. | Postgrad Med J | 2026 | 41474140 | PubTator, text mining | PubMed |
| Phosphorylation of CBX8 by PKD1 suppresses PRC1 activity and promotes cell senescence. | Oncogene | 2026 | 41398073 | PubTator, text mining | PubMed |
| Raman imaging uncovers Ebracteolatain A's subtype-selective metabolic reprogramming in luminal versus triple-negative breast cancer cells. | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 41370914 | PubTator, text mining | PubMed |
| Tetralogy of Fallot and craniosynostosis - differential manifestation in a familial case of CHDED syndrome caused by novel pathogenic PRKD1 variant. | J Hum Genet | 2026 | 41136760 | PubTator, text mining | PubMed |
| Commentary on "Targeting protein kinase D in oral squamous cell carcinoma: a promising therapeutic approach" by Dandapani. | Int J Surg | 2026 | 40928284 | PubTator, text mining | PubMed |
| Improving our understanding of the biology of aging: findings from the Age-It Research Program. | J Gerontol B Psychol Sci Soc Sci | 2025 | 41442755 | PubTator, text mining | PubMed |
| L1 modulates protein kinase D1 (PKD1) phosphorylation during H2O2-induced cell senescence. | Folia Neuropathol | 2025 | 41367336 | PubTator, text mining | PubMed |
| Protein kinase D2-mediated maintenance complex component 2 phosphorylation promotes bladder cancer progression. | J Transl Med | 2025 | 41299687 | PubTator, text mining | PubMed |
| The proton-sensing OGR1 receptor and hypoxia-inducible factors promote metal ion-induced inflammatory responses in coronary artery smooth muscle cells. | J Biol Chem | 2025 | 41135674 | PubTator, text mining | PubMed |
| Activation of the Piezo1 channel stimulates protein kinase D and migration in human aortic endothelial cells. | Am J Physiol Cell Physiol | 2025 | 41071645 | PubTator, text mining | PubMed |
| RhoA allosterically activates phospholipase Cε via its EF hands. | Commun Biol | 2025 | 41006770 | PubTator, text mining | PubMed |
| Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K. | J Funct Biomater | 2025 | 41003423 | PubTator, text mining | PubMed |
| Protein Kinase D1 (PRKD1) as a Diagnostic, Prognostic, and Immunomodulatory Biomarker in Human Cancers. | Cureus | 2025 | 40984898 | PubTator, text mining | PubMed |
| SoxB1-Mediated Chromatin Remodeling Promotes Sensory Neuron Differentiation in Planarians. | bioRxiv | 2025 | 40950109 | PubTator, text mining | PubMed |
| Hedgehog Components Are Present in Polymorphous Adenocarcinoma of the Salivary Gland Regardless of PRKD1 Mutation and Tissue Invasion. | J Oral Pathol Med | 2025 | 40930949 | PubTator, text mining | PubMed |
| Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome. | Dermatopathology (Basel) | 2025 | 40843798 | PubTator, text mining | PubMed |
| miR-590-5p mediates mitochondrial respiration, proliferation, and apoptosis in thyroid carcinoma cells via fibroblast growth factor receptor substrate 2. | Arch Endocrinol Metab | 2025 | 40834280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5587/papers?page=3